Professional Documents
Culture Documents
Principles of Diuretic Therapy: Dr. Rania Magadmi, MBBS, PHD
Principles of Diuretic Therapy: Dr. Rania Magadmi, MBBS, PHD
Diuretic Therapy
Dr. Rania Magadmi, MBBS, PhD
Assistant Professor, Pharmacology
department, Faculty of Medicine,
KAU
1
Objectives:
1. Review the structure and function of the nephron.
2. Classify the major classes of diuretics.
3. Discuss the main site of action ,mechanisms, indications and
adverse effects of each class of diuretics.
• Urine is formed in 3 processes:
t ly
os
m
CT
+
a
-
N DCT
l
C
Na+
PCT 1%
DL TAL 25%
5
PT 1. Carbonic anhydrase inhibitors: Acetazolamide
Carbonic
anhydrase
inhibitors PT
Lumen blood
Na+
Na+ ATP
K+
HCO3- + H+ H+ HCO3-
H2CO3
H2CO3
CA CA
H2O +CO2 H2O +CO2
Acetazolamide
PT 1. Carbonic anhydrase inhibitors: Acetazolamide
Mechanism of action
Carbonic
anhydrase Inhibits carbonic anhydrase enzyme in PCT à interferes
inhibitors with NaHCO3 reabsorption .
- Increase excretion of Na+, HCO3-, H2O, K+ “Alkaline diuresis”
- Metabolic acidosis.
- Weak diuretics.
Therapeutic uses:
- Glaucoma (reduce formation of aqueous humor by
blocking carbonic anhydrase in ciliary body of eye).
- Mountain sickness
- Epilepsy (decrease cerebrospinal fluid volume-CSF).
Adverse effects
- Ca and Phosphate renal stones (due to alkaline urine).
- Metabolic acidosis (drowsiness)
- Hypokalemia (potassium loss).
TAL 2. Loop diuretics:
Furosemide, Torsemide, Bumetanide
Loop diuretic
Loop Diuretics
Therapeutic uses:
- Are widely used drugs (drug of choice) for emergency:
- Acute pulmonary edema of heart failure
- Acute hypertensive encephalopathy.
- The major application is in the treatment of edematous states (e.g
heart failure, ascites, liver faliure, acute renal failure).
TAL 2. Loop diuretics:
Furosemide, Torsemide, Bumetanide
Loop diuretic
Adverse effects
1. Metabolic alkalosis.
2. Acute hypovolemia: hypotension and collapse.
3. Hyponatremia, Hypomagnesaemia, Hypocalcemia.
4. Hypokalemia .
5. Hyperuricemia: competes with transport of uric acidà
block uric acid secretion.
6. Osteoporosis (Chronic use)
7. Ototoxicity; altered electrolyte handling in the endolymph
(particularly when used together with aminoglycoside
antibiotics).
DT 3. THIAZIDE DIURETICS
THIAZIDE
DIURETICS
Thiazide
diuretics
Na+/Cl- co-
transporter
Na+/K+ ATPase
Na+/Ca++ exchanger
DT 3. THIAZIDE DIURETICS
• Hydrochlorothiazide
• Chlorthalidone (Taken once daily)
THIAZIDE • Indapamide " Thiazide-like diuretics“
DIURETICS • Metolazone Less renal toxicity
Mechanism of action
- Decrease NaCl reabsorption via inhibition of Na+/Cl- in DCT (~ 5-8% of
Na+ reabsorption)àModerate diuretics..
- Ca++ is reabsorbed. Thus patients on thiazides have a reduced risk for
osteoporosis (so preferred in elderly hypertensive patients).
Therapeutic uses:
1. The major application is in hypertension.
2. Heart failure ( loop diuretics are drug of choice in reducing
extracellular volume, thiazide may be added if needed).
DT 3. THIAZIDE DIURETICS
THIAZIDE
DIURETICS Adverse effects
1. Metabolic alkalosis
2. Electrolytes imbalance: Hypokalemia, Hyperuricemia,
Hypercalcemia.
3. Hyperglycemia (chronic use)
(if the patient is diabetic monitor his blood glucose)
4. Hyperlipidemia: - Decreased insulin levels and high glucose
levels being converted to fat instead of going through
metabolism.
14
• Now:
1. Carbonic anhydrase inhibitors
2. Loop Diuretics (Furosemide,)
3. Thiazide diuretics
K + wasters
K+-SPARING
DIURETICS CT Interstitium/
Lumen
Cl- blood
Triamterene Na+
Amiloride Na+ ATP
K+
K+
Spironlactone
Aldosterone
Principal cell
Intercalated
cell
CT 4. K+-SPARING DIURETICS (Spironolactone,
Amiloride, Triamterene)
K+-SPARING Mechanism of action
DIURETICS
- Spironolactone is a competitive antagonist to aldosterone.
- Triamterene and Amiloride inhibit Na+ reabsorption from
collecting ducts (K-sparing effect).
Therapeutic uses:
- Drug of choice for patient with hepatic cirrhosis due to elevated serum
aldosterone levels (aldosteronism).
- Diuretics in combination with thiazide or loop diuretics (to correct for
hypokalemia).
Adverse effects
- Hyperkalemia.
- Metabolic acidosis.
- Gynecomastia in male and menstrual irregularities in females.
PT, LH, CT 5. OSMOTIC DIURETICS
MANNITOL
OSMOTIC
DIURETICS
PT, LH, CT 5. OSMOTIC DIURETICS
MANNITOL
OSMOTIC
Mechanism of action
DIURETICS Freely filtered at the glomerulus but not reabsorbed or
secreted, mannitol remains in the lumen and ‘‘holds’’ water by
its osmotic effect.
Pharmacokinetics
Not absorbed orally - Given only I.V.
- Acts in proximal convoluted tubules; descending
loop of Henle and collecting tubule
Adverse effects
- Dehydration, Adequate water replacement is required.
Nursing notes
• Weight the patient each morning
(indicator of the patient’s response to
diuretics).
• Watch the patient at risk for injury
related to postural hypotension and
dizziness.
• Give the diuretic in the morning to
prevent nocturia from disturbing the
patient’s sleep.
• Ask the patient taking loop and thiazide
diuretics to consume plenty of
potassium-rich foods.
20
Osmotic diuretics Carbonic anhydrase Thiazide diuretic (Hydrochlorothiazide)
(Mannitol) inhibitors (Acetazolamide) Therapeutic uses: diuretic of choice in treatment of
Therapeutic uses: Therapeutic uses: for glaucoma & Hypertension.
Increased ICP, Cerebral Mountain sickness. Adverse effects: hypokalemia, Hypercalcemia,
edema, Acute renal failure. Adverse effects: hypokalemia & Hyperuricemia, hyperglycemia, hyperlipidemia.
Adverse effects: metabolic acidosis.
Dehydration.
-
- +
a
N
PCT
-
l DCT
C
TAL
CT
-
Loop diuretic -
(Furosemide) K+-Sparing Diuretics
Therapeutic uses: The diuretic (Spironolactone)
of choice in treatment of acute Therapeutic uses: used in combination
pulmonary edema of HF & with other diuretics. It is the diuretic of
edematous states. choice for patient with hepatic cirrhosis.
Adverse effects: hypokalemia, Adverse effects: Hyperkalemia, Metabolic
Hyperuricemia, osteoporosis & acidosis & Gynecomastia.
ototoxicity.
21
Thank you
rmagadmi@kau.edu.sa
22
References
https://kahoot.it
https://kahoot.it/challenge/07636057?challenge-id=75f175e6-4003-
4fac-b012-75f890f90143_1602535842572